BHF - Brighthouse Financia... Stock Analysis | Stock Taper
Logo
Brighthouse Financial, Inc.

BHF

Brighthouse Financial, Inc. NASDAQ
$59.98 -0.38% (-0.23)

Market Cap $3.43 B
52w High $66.33
52w Low $42.07
P/E 4.21
Volume 944.64K
Outstanding Shares 57.18M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $1.56B $709M $137M 8.8% $1.96 $188M
Q3-2025 $1.71B $287M $479M 28.04% $7.93 $623M
Q2-2025 $790M $401M $85M 10.76% $1.05 $131M
Q1-2025 $2.32B $423M $-268M -11.55% $-5.04 $-316M
Q4-2024 $1.08B $351M $671M 62.3% $11.02 $872M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $5.39B $240.74B $233.91B $6.77B
Q3-2025 $6.61B $243.7B $237.27B $6.36B
Q2-2025 $5.54B $241.56B $235.82B $5.67B
Q1-2025 $4.67B $233.77B $228.46B $5.24B
Q4-2024 $5.04B $239.27B $234.24B $4.96B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $433M $-364M $-1.88B $640M $-1.61B $-364M
Q3-2025 $-268M $117M $1.37B $-423M $1.07B $117M
Q2-2025 $268M $-1M $112M $762M $873M $-1M
Q1-2025 $-268M $146M $563M $-1.09B $-378M $146M
Q4-2024 $0 $-118M $-357M $-110M $-585M $-118M

Revenue by Products

Product Q3-2024Q1-2025Q2-2025Q3-2025
Accident and Health Insurance Product Line
Accident and Health Insurance Product Line
$0 $0 $10.00M $10.00M
Investment Product
Investment Product
$0 $590.00M $580.00M $560.00M
Life Insurance Product Line
Life Insurance Product Line
$0 $280.00M $280.00M $270.00M
Variable Annuity
Variable Annuity
$10.00M $0 $0 $0

Q2 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Brighthouse Financial, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key strengths include a focused business model in attractive retirement segments, strong gross and operating profitability, and a very liquid balance sheet with meaningful cash and a net cash position after debt. The company also benefits from deep advisor relationships, recognized product franchises in Shield annuities and SmartCare, and disciplined risk management that supports its capital profile. Together, these elements make for a business that is commercially relevant, operationally viable, and financially flexible in the near term.

! Risks

Major risks center on weak cash flow generation in the latest period, negative retained earnings from historical losses, and the inherent leverage and complexity of a large insurance balance sheet. Competitive pressure, regulatory and interest‑rate volatility, and the ease with which rivals can launch similar products all weigh on pricing power and margins. The move to private ownership under Aquarian introduces additional uncertainty around strategy, capital allocation, risk appetite, and how aggressively the company may pursue growth versus balance sheet conservatism.

Outlook

The outlook appears balanced: Brighthouse has a solid market position, healthy current profitability, and strong reported liquidity, but faces questions about the quality and sustainability of cash flows and the long‑term trajectory of earnings. If the Aquarian acquisition successfully brings additional investment, operational improvement, and thoughtful product and technology enhancements, the franchise could strengthen further. At the same time, the combination of competitive intensity, structural leverage, and shifting ownership means future performance is likely to be more sensitive to execution and risk management than the current snapshot alone might imply.